OPINION — With the holiday season behind us, Medicare Part D open enrollment has just wrapped up. This program gives seniors the gift of peace of mind. For millions of older Americans, Medicare Part D isn’t just a program — it’s a promise. And according to a recent Morning Consult survey for the Medicare Today coalition, 93% of seniors say they’re satisfied with their Part D prescription drug coverage.
Despite earning this exceptional approval from constituents, policymakers are advancing proposals that threaten to erode Medicare’s value and the access to care on which seniors depend. Recently announced Most Favored Nation drug-pricing demonstrations would introduce sweeping price controls that could undermine the program’s effectiveness. At the same time, Congress is weighing an expansion of the Inflation Reduction Act’s Medicare’s drug price-setting authority, potentially doubling down on policies that prioritize cost savings for the federal government over patient care.
Although price control policies are presented as a seemingly beneficial approach, in reality, they would stifle innovation and limit access to existing cures. Seniors want affordability, but not at the expense of choice or quality of care.
